A study published in the June 2025 issue of Journal of Neurology reported that structural changes in the retina, as detected ...

As part of Care Home Open Week, Pemberley House was delighted to host ‘The Great Mobility Scooter Event’ at War Memorial Park ...

No two disabled people are the same, and no two days are alike—yet current disability assessments fail to recognise this ...

In people with benign MS, there is a loss of overall brain tissue but other parts of the brain may grow to help compensate for the damage, a study suggests.

Multiple sclerosis (MS) includes both peripheral and central nervous system (CNS) inflammation, and an anti-inflammatory ...

Enrollment is now complete in two Phase 3 clinical trials testing vidofludimus calcium in adults with relapsing forms of ...

Reduction of confirmed disability worsening is widely considered to be the most recognized regulatory approval endpoint for registrational studies in progressive forms of multiple sclerosis (MS).

slowed disability progression by 31% in patients with nonrelapsing secondary progressive multiple sclerosis (nrSPMS), results of a multi-center phase 3 study showed. “Although tolebrutinib was ...

The drug, tolebrutinib, delayed disability progression by 31% in people with a type of MS called non-relapsing secondary progressive multiple sclerosis, researchers reported in the New England ...

Throughout the course of multiple sclerosis, gradually progressive neurologic impairment can occur, which has been called disability accrual. Current disease-modifying therapies for multiple ...

SAN DIEGO — Treatment with tolebrutinib led to greater confirmed disability improvement at 6 months compared with placebo in patients with non-relapsing secondary progressive multiple sclerosis ...

Cite this: Fish-Rich Diet May Slow Multiple Sclerosis Disability Progression - Medscape - March 04, 2025. Comments Commenting is limited to medical professionals.